Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Multiple Myeloma & Renal Cell Carcinoma Have Something In Common: Recent Improvement In Treatment Results–But Still No Cure

Home/Multiple Myeloma & Renal Cell Carcinoma Have Something In Common: Recent Improvement In Treatment Results–But Still No Cure

Multiple Myeloma & Renal Cell Carcinoma Have Something In Common: Recent Improvement In Treatment Results–But Still No Cure

I don’t know if you have had time to follow our exchange or not, but a reader named Steven and I have been swapping comments over Friday’s article about stem cell transplants (SCT). The conversation has centered on the sequence of treatment. Which makes more sense—moving to SCT immediately after induction therapy starts to work—or waiting. My response: No one knows for sure which is better.

While writing an article on my other daily blog, http://www.helpwithcancer.org/, about skin cancer, this statement caught my eye:  “However, the best way to use these sequences is emperical.” This quote is from renal cell carcinoma specialist Dr. Bernard Escudier. Apparently, like multiple myeloma, renal cell carcinoma researchers have made dramatic progress in extending patient’s lives over the past four years. But unfortunately, like multiple myeloma, renal cell carcinoma is rarely cured. Missery loves company, I guess—but I find comfort in knowing our cancer is not the only one which is tantilizingly close to a cure.

Feel good and keep smiling! Pat